M
MBX Biosciences Inc
NASDAQ:MBX
MBX Biosciences Inc
NASDAQ:MBX
Price:
34.79
USD
-6.63%
Market Closed
Market Cap:
$1.6B
Balance Sheet
Balance Sheet Decomposition
MBX Biosciences Inc
MBX Biosciences Inc
Balance Sheet Decomposition is not available for
MBX Biosciences Inc
MBX Biosciences Inc
Balance Sheet
MBX Biosciences Inc
MBX Biosciences Inc
Currency: USD
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
24
|
31
|
49
|
|
| Cash Equivalents |
24
|
31
|
49
|
|
| Short-Term Investments |
18
|
50
|
213
|
|
| Total Receivables |
0
|
0
|
1
|
|
| Other Current Assets |
2
|
3
|
4
|
|
| Total Current Assets |
44
|
83
|
267
|
|
| PP&E Net |
1
|
1
|
1
|
|
| PP&E Gross |
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
|
| Total Assets |
45
N/A
|
84
+87%
|
269
+219%
|
|
| Liabilities | ||||
| Accounts Payable |
1
|
1
|
5
|
|
| Accrued Liabilities |
2
|
3
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
4
|
11
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
4
+12%
|
11
+159%
|
|
| Equity | ||||
| Common Stock |
84
|
152
|
0
|
|
| Retained Earnings |
43
|
76
|
138
|
|
| Additional Paid In Capital |
0
|
3
|
395
|
|
| Other Equity |
0
|
0
|
0
|
|
| Total Equity |
41
N/A
|
80
+94%
|
257
+222%
|
|
| Total Liabilities & Equity |
45
N/A
|
84
+87%
|
269
+219%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
32
|
32
|
33
|
|
Switch to:
Switch to:
See Also
Discover More
